26455-1-AP
antibody from Proteintech Group
Targeting: LILRB1
CD85, CD85j, ILT2, LIR-1, LIR1, MIR-7, PIR-B, PIRB
Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 26455-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- LILRB1 antibody
- Antibody type
- Polyclonal
- Description
- LILRB1 antibody (Cat. #26455-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: FC, IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references LILRB1 Is a Prognostic-Related Biomarker Correlated With Immune Infiltration in Head-Neck Squamous Cell Carcinoma.
LILRB1(+) immune cell infiltration identifies immunosuppressive microenvironment and dismal outcomes of patients with ovarian cancer.
Chen S, Wu Q, Gu S, Zhou Y, Cai M, Wu J, He J, He J, Lin J, Hong Z, Zhang B, Luo X
Cancer medicine 2026 Mar;15(3):e71727
Cancer medicine 2026 Mar;15(3):e71727
LILRB1(+) immune cell infiltration identifies immunosuppressive microenvironment and dismal outcomes of patients with ovarian cancer.
Xu X, Yin S, Wang Y, Zhu Q, Zheng G, Lu Y, Li T, Zhu C
International immunopharmacology 2023 Jun;119:110162
International immunopharmacology 2023 Jun;119:110162
No comments: Submit comment
No validations: Submit validation data